OncoSec Medical Incorporated ONCS NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

Il y a eu 50 transactions d'initiés récentes enregistrées pour OncoSec Medical Incorporated (ONCS), dont 28 achats et 17 ventes. Le total des achats d'initiés s'élève à $10.66M et le total des ventes d'initiés à $1.2M.

Les initiés notables ayant une activité récente comprennent Delaversano Robert J, Foster Spahr Stephany, Arch Robert H.. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — ONCS

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2023-02-09	Delaversano Robert J	VP, Finance	Vente Informative	40	$1.37	$54.80	1,008
2022-11-04	Delaversano Robert J	VP, Finance	Vente Informative	283	$0.37	$104.71	22,975
2022-10-07	Foster Spahr Stephany	Director	Inconnu	-	-	-	-
2022-10-07	Foster Spahr Stephany	Director	Attribution de RSU	50,000	-	-	50,000
2022-08-05	Delaversano Robert J	VP, Finance	Vente Informative	284	$0.71	$201.64	23,258
2022-05-06	Delaversano Robert J	VP, Finance	Vente Informative	274	$0.83	$227.42	23,542
2022-05-02	Arch Robert H.	Officer	Inconnu	-	-	-	-
2022-05-02	Arch Robert H.	President and CEO	Attribution de RSU	700,000	-	-	700,000
2022-02-17	Chi George	Officer	Inconnu	-	-	-	-
2022-02-09	Delaversano Robert J	VP, Finance	Vente Informative	409	$0.88	$359.92	23,816
2021-12-17	Shi Lin	Director	Inconnu	-	-	-	-
2021-11-01	Delaversano Robert J	VP, Finance	Vente Informative	343	$1.75	$600.25	24,225
2021-08-23	Zhao Yuhang	Director	Achat Informatif	4,000	$1.88	$7.52K	12,000
2021-08-23	Dalesandro Margaret	Director	Achat Informatif	20,000	$1.89	$37.8K	20,000
2021-08-20	Zhao Yuhang	Director	Achat Informatif	8,000	$1.94	$15.52K	8,000
2021-08-02	Delaversano Robert J	VP, Finance	Vente Informative	412	$2.18	$898.16	24,568
2021-06-28	Dalesandro Margaret	Director	Attribution de RSU	37,500	$3.16	$118.5K	37,500
2021-06-28	Demesa James M	Director	Attribution de RSU	25,000	$3.16	$79K	25,000
2021-06-28	Ward Robert	Director	Attribution de RSU	25,000	$3.16	$79K	25,000
2021-06-28	Leuthner Brian A	Interim CEO	Attribution de RSU	33,000	$3.16	$104.28K	33,000
2021-06-28	Delaversano Robert J	Vice President, Finance	Attribution de RSU	35,000	$3.16	$110.6K	35,000
2021-06-28	Kim Joon	Director	Attribution de RSU	25,000	$3.16	$79K	25,000
2021-06-28	Zhao Yuhang	Director	Attribution de RSU	25,000	$3.16	$79K	25,000
2021-06-28	Smith Kevin Raymond Merrill	Director	Attribution de RSU	25,000	$3.16	$79K	25,000
2021-06-28	Zhou Chao	10 Percent Owner	Attribution de RSU	25,000	$3.16	$79K	25,000
2021-06-28	Lyerly Herbert Kim	Director	Attribution de RSU	25,000	$3.16	$79K	25,000
2021-05-03	Delaversano Robert J	VP, Finance	Vente Informative	453	$4.86	$2.2K	24,980
2021-04-30	O'connor Daniel J.	CEO and President	Vente Informative	3,172	$4.86	$15.42K	96,097
2021-04-16	China Grand Pharmaceutical & Healthcare Holdings Ltd	10 Percent Owner	Achat Informatif	281,968	$3.45	$972.79K	3,359,607
2021-02-18	Alpha Holdings, Inc.	Director	Exercice d'Options (ITM)	368,250	$3.45	$1.27M	-
2021-02-02	Leuthner Brian A	Officer	Inconnu	-	-	-	-
2021-02-02	Leuthner Brian A	Chief Operating Officer	Attribution de RSU	150,000	$7.45	$1.12M	150,000
2021-02-01	O'connor Daniel J.	CEO and President	Vente Informative	3,413	$7.71	$26.31K	99,269
2021-02-01	Delaversano Robert J	Principal Accounting Officer	Attribution de RSU	8,750	-	-	25,433
2021-01-25	China Grand Pharmaceutical & Healthcare Holdings Ltd	10 Percent Owner	Achat Informatif	677,839	$5.45	$3.69M	3,077,639
2020-11-20	Alpha Holdings, Inc.	Director	Vente Informative	80,000	$4.92	$393.87K	1,350,001
2020-11-19	Alpha Holdings, Inc.	Director	Vente Informative	50,000	$5.10	$255.23K	1,430,001
2020-11-18	Alpha Holdings, Inc.	Director	Vente Informative	10,999	$5.24	$57.65K	1,480,001
2020-11-17	Alpha Holdings, Inc.	Director	Vente Informative	40,000	$5.17	$206.74K	1,531,000
2020-11-16	Alpha Holdings, Inc.	Director	Vente Informative	40,000	$5.41	$216.33K	1,571,000
2020-11-02	O'connor Daniel J.	CEO and President	Vente Informative	3,280	$3.79	$12.43K	102,682
2020-09-14	Dalesandro Margaret	Director	Attribution de RSU	25,000	$3.43	$85.75K	25,000
2020-09-14	Demesa James M	Director	Attribution de RSU	50,000	$3.43	$171.5K	50,000
2020-09-14	Ward Robert	Director	Attribution de RSU	25,000	$3.43	$85.75K	25,000
2020-09-14	Lyerly Herbert Kim	Director	Attribution de RSU	25,000	$3.43	$85.75K	25,000
2020-08-24	O'connor Daniel J.	CEO and President	Attribution de RSU	152,000	$3.82	$580.64K	152,000
2020-08-24	Delaversano Robert J	Principal Accounting Officer	Attribution de RSU	27,000	$3.82	$103.14K	27,000
2020-08-24	Foerter Kellie Malloy	Chief Operating Officer	Attribution de RSU	65,000	$3.82	$248.3K	65,000
2020-08-19	China Grand Pharmaceutical & Healthcare Holdings Ltd	10 Percent Owner	Achat Informatif	399,800	$3.25	$1.3M	2,399,800
2020-07-31	O'connor Daniel J.	CEO and President	Vente Informative	3,133	$4.20	$13.16K	105,962

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration